Follow-up of Migraine Patients on Eptinezumab

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

August 31, 2024

Study Completion Date

August 31, 2024

Conditions

Migraine

Interventions

OTHER

None, pure observationnal study

Pure observatonnal study

Trial Locations (2)

CHU de Nîmes, Nîmes

CH de Saint Denis, Saint-Denis

All Listed Sponsors

lead

Centre Hospitalier Universitaire de Nīmes

OTHER

NCT06446804 - Follow-up of Migraine Patients on Eptinezumab | Biotech Hunter | Biotech Hunter